Atlas Trials

Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves

Clinical trial NCT07610174 · COMPLETED

Trial details

NCT number
NCT07610174
Sponsor
Kafrelsheikh University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Heart FailureHeart Valve Prosthesis
Start date
2025-06-02
Primary completion
2026-04-29
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.